EUVIMEDEUVIMED entdecken
Crossref

The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study

Erfan Ghadirzadeh, Seyed Pooria Salehi Mashhad Sari, Saeed Saed, Mobina Gheibi, Arya Asadi Rad, Samaneh Rahimi Bidrouni, Ghazal Mohseni, Ali Siahposht-Khachaki

Behavioural Brain Research · 2026

DOI: 10.1016/j.bbr.2025.115943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2026. Verfasst von Erfan Ghadirzadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Non-Communicable Diseases Institute, Mazandara…. Hauptthemen laut MEDLINE: Erythropoietin, Brain Injuries, Traumatic, Neuroprotective Agents, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While some animal studies have shown that erythropoietin (EPO) can reduce neuronal death and improve cognitive outcomes after traumatic brain injury (TBI), inconsistencies exist in research findings, possibly due to differences in dosage, timing, and injury models. Specifically, the role of EPO in modulating the AMP-activated protein kinase (AMPK) pathway remain unclear. Thus, this study aims to address these gaps by investigating the effects of EPO on neurobehavioral outcomes, brain edema, blood-brain barrier (BBB) permeability, and the AMPK pathway in a severe TBI rat model. METHODS: 112 male Albino Wistar rats were traumatized by free-fall weight dropping Marmarou TBI induction method in eight groups (14 rats each): Intact, Sham, TBI, Saline (TBI + saline injection as placebo), intraperitoneal injection of EPO in 2500, 5000, and 10000 IU/kg doses, and Compound-C (TBI + Compound-C + EPO 5000) group. Cerebral edema, BBB permeability (via Evans blue method), veterinary coma scale (VCS), beam-walk (BW), beam-balance (BB), and p-AMPK/AMPK ratio (through enzyme-linked immunosorbent assay) were evaluated after trauma. RESULTS: Administration of EPO at 2500 and 5000 IU/kg yielded lower brain water content, improved BBB integrity, better VCS, BW, and BB scores, and higher p-AMPK/AMPK ratio (all P < 0.01). Though the 5000 IU/kg dose was also effective, the 2500 IU/kg dose exhibited superior results. Notably, an escalation to 10000 IU/kg or addition of Compound-C worsened the results, suggesting a dose-dependent threshold for EPO's efficacy, and the potential role of AMPK pathway, respectively. CONCLUSION: Our results suggest that EPO may exert neuroprotective effects in TBI-induced rats via modification of the AMPK pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythropoietinBrain Injuries, TraumaticNeuroprotective AgentsAMP-Activated Protein KinasesAnimalsMaleRats, WistarBlood-Brain BarrierBrain EdemaRatsDisease Models, AnimalSignal TransductionBehavior, AnimalDose-Response Relationship, Drug

Stichwörter der Autor:innen

AMP-activated protein kinaseBBB disruptionErythropoietinNeuroprotectiveRatTraumatic brain injury

Substanzen

ErythropoietinNeuroprotective AgentsAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: er.g…
  • Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
  • Department of Pharmacology Sciences, School of Pharmacy, Mazandaran University of Medical Sciences, Ramsar, Iran.
  • Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran; Department of Medical Laboratory Sciences, Razi Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
  • Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Immunogenetics Research Center, Department of Physiology, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: ak57n@yahoo.com.

Zitieren

APA

Ghadirzadeh, E., Salehi Mashhad Sari, S. P., Saed, S., Gheibi, M., Asadi Rad, A., Rahimi Bidrouni, S., Mohseni, G., & Siahposht-Khachaki, A. (2026). The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2025.115943

Vancouver

Ghadirzadeh E, Salehi Mashhad Sari SP, Saed S, Gheibi M, Asadi Rad A, Rahimi Bidrouni S, et al. The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study. Behavioural Brain Research. 2026. doi:10.1016/j.bbr.2025.115943

BibTeX
@article{Ghadirzadeh2026,
  author = {Ghadirzadeh, Erfan and Salehi Mashhad Sari, Seyed Pooria and Saed, Saeed and Gheibi, Mobina and Asadi Rad, Arya and Rahimi Bidrouni, Samaneh and Mohseni, Ghazal and Siahposht-Khachaki, Ali},
  title = {The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study},
  journal = {Behavioural Brain Research},
  year = {2026},
  doi = {10.1016/j.bbr.2025.115943}
}
Kostenlos starten →